A decision on the company’s new drug application for its experimental NASH therapy is expected in the spring. Click here to view original post
CureVac is expecting good news in its patent infringement cases for components of its Covid-19 vaccine against Pfizer partner BioNTech in Germany after a court postponed proceedings on four cases, the company announced Thursday. CureVac […]
NEW YORK, NY (September 28, 2023) — “There can be a stigma and secrecy when it comes to cancer,” says Dr. Balogun. “Sometimes there’s an underappreciation for the fact that what’s ailing you might also […]
Penn’s cell and gene therapy pioneer doesn’t believe the dramatic slowdown in investment capital to the sector can get any worse. Click here to view original post
BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth Launches Q3 2023 Specialty & Rare Pipeline Digest™: Expert Resource for FDA Approval Status of Specialty Pharmaceuticals & CGT Click here to view original post
The company has now raised more than $36 million since its inception. Click here to view original post
Merck said on Thursday that it will participate “under protest” in the first round of price negotiations with the Centers for Medicare and Medicaid Services for its type 2 diabetes treatment Januvia (sitagliptin). The company […]
Ophthalmologists who accepted payments from drug companies were less likely to prescribe a cheaper medicine to treat an eye disease that causes blindness in older people, according to a new… Click here to view original […]
Temporary Implanted Prostatic Devices Added to AUA Clinical Practice Guideline CENTER VALLEY, Pa., Sept. 28, 2023 /PRNewswire/ — Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, […]
Biogen axed its 23,000-person cognitive health study with Apple phones and watches last week as part of a broader pullback in the biotech’s fledgling digital health unit, per an update to a US federal trials […]
Copyright © 2023 Biotech Networks, LLC
